http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104569396-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2015-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104569396-B |
| titleOfInvention | Diagnosing cancer of liver reagent and application thereof |
| abstract | The present invention relates to diagnosing cancer of liver reagent and application thereof.Specifically, the purposes the present invention relates to the combination of one or more of TGF β 1 or TGF β 1 and alpha-fetoprotein or TGF β 1 and other conventional liver cancer Testing index or the combination of one or more of TGF β 1 and alpha-fetoprotein and other conventional liver cancer Testing index in the reagent of diagnosing liver cancer is prepared.The diagnosing cancer of liver mark single index uses of TGF β 1 of the present invention can subregion liver cancer group and normal group, it is basic to distinguish liver cancer group and other cancer groups and liver cancer group and hepatitis group, be used in combination with other conventional liver cancer Testing index then better. |
| priorityDate | 2015-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.